HK1226085A1 - 一種網紅細胞生長因子及其製備方法和應用 - Google Patents

一種網紅細胞生長因子及其製備方法和應用

Info

Publication number
HK1226085A1
HK1226085A1 HK16114515A HK16114515A HK1226085A1 HK 1226085 A1 HK1226085 A1 HK 1226085A1 HK 16114515 A HK16114515 A HK 16114515A HK 16114515 A HK16114515 A HK 16114515A HK 1226085 A1 HK1226085 A1 HK 1226085A1
Authority
HK
Hong Kong
Prior art keywords
preparation
application
growth factor
reticulocyte growth
reticulocyte
Prior art date
Application number
HK16114515A
Other languages
English (en)
Inventor
Yifeng Jin
Qi Wu
Taiping Zhang
Xiaoyan Ma
Ji Xuan
Original Assignee
Nanjing Biyoukang Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Biyoukang Biotechnology Co Ltd filed Critical Nanjing Biyoukang Biotechnology Co Ltd
Publication of HK1226085A1 publication Critical patent/HK1226085A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Analytical Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
HK16114515A 2014-01-24 2016-12-21 一種網紅細胞生長因子及其製備方法和應用 HK1226085A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410036118.XA CN103804484B (zh) 2014-01-24 2014-01-24 一种网红细胞生长因子及其制备方法和应用

Publications (1)

Publication Number Publication Date
HK1226085A1 true HK1226085A1 (zh) 2017-09-22

Family

ID=50701913

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16114515A HK1226085A1 (zh) 2014-01-24 2016-12-21 一種網紅細胞生長因子及其製備方法和應用

Country Status (11)

Country Link
US (1) US20160326226A1 (zh)
EP (1) EP3098233A4 (zh)
JP (1) JP6434525B2 (zh)
KR (1) KR20160111909A (zh)
CN (1) CN103804484B (zh)
AU (2) AU2014379070A1 (zh)
CA (1) CA2930049A1 (zh)
HK (1) HK1226085A1 (zh)
NZ (1) NZ719356A (zh)
RU (1) RU2703176C2 (zh)
WO (1) WO2015109604A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106279406B (zh) * 2016-08-05 2019-08-20 南京必优康生物技术有限公司 猪皮中分离纯化的皮抑素g1的活性成分四连接素及其应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3585969D1 (de) * 1984-06-14 1992-06-11 Chiron Corp Protease-inhibitoren des alpha-1-antitrypsin typs mit modifizierter aktiever stelle und deren herstellung.
US4667016A (en) * 1985-06-20 1987-05-19 Kirin-Amgen, Inc. Erythropoietin purification
JPH06116300A (ja) * 1992-10-07 1994-04-26 Seiwa Kasei:Kk ケラチンフラグメントおよびその製造方法
US5861483A (en) * 1996-04-03 1999-01-19 Pro-Neuron, Inc. Inhibitor of stem cell proliferation and uses thereof
EP1415664A1 (en) * 2002-10-30 2004-05-06 Switch Biotech Aktiengesellschaft Use of alpha 1-antichymotrypsin in combination with alpha-1-antitrypsin for treating/preventing diabetes associated or poorly healing arterial wounds
PL2520654T3 (pl) * 2003-08-26 2017-08-31 The Regents Of The University Of Colorado, A Body Corporate Inhibitory aktywności proteazy serynowej i ich zastosowanie w sposobach i kompozycjach do leczenia zakażeń bakteryjnych
US9457070B2 (en) * 2005-06-07 2016-10-04 The Regents Of The University Of Colorado, A Body Corporate Compositions, methods and uses of alpha 1-antitrypsin for early intervention in bone marrow transplantation and treatment of graft versus host disease
US8715649B2 (en) * 2005-06-07 2014-05-06 The Regents Of The University Of Colorado, A Body Corporate Compositions and methods of use for alpha-1 antitrypsin having no significant serine protease inhibitor activity
US20070218535A1 (en) * 2005-11-28 2007-09-20 Xinli Lin Methods for production of recombinant alpha1-antitrypsin
US20070280922A1 (en) * 2006-06-06 2007-12-06 Zoltan Kiss Consulting Combinations of human proteins to enhance viability of stem cells and progenitor cells
CN100562523C (zh) * 2006-07-26 2009-11-25 河北大安制药有限公司 α1-抗胰蛋白酶的制备方法
WO2008033890A2 (en) * 2006-09-12 2008-03-20 Beth Israel Deaconess Medical Center, Inc. Compositions containing alpha-1-antitrypsin and methods for use
WO2008065372A2 (en) * 2006-11-28 2008-06-05 Nautilus Biotech, S.A. Modified erythropoietin polypeptides and uses thereof for treatment
PT2391654E (pt) * 2009-01-28 2015-11-19 Ind Tech Res Inst Biomarcadores na urina e séricos associados com nefropatia diabética
US8703487B2 (en) * 2009-12-01 2014-04-22 The Regents Of The University Of California Compositions and methods for making and using bone marrow mesenchymal stem cells and erythroid progenitor cells
CN102206272B (zh) * 2009-12-11 2014-10-01 普罗特奥姆技术公司 生产重组α1-抗胰蛋白酶的方法
WO2011109768A2 (en) * 2010-03-04 2011-09-09 The Regents Of The University Of Colorado, A Body Corporate Compositions and methods for modulating cardiac conditions
US8557961B2 (en) * 2010-04-02 2013-10-15 Amunix Operating Inc. Alpha 1-antitrypsin compositions and methods of making and using same
CN102180966B (zh) * 2011-01-28 2013-04-03 哈尔滨派斯菲科生物制药股份有限公司 一种规模化生产人α1-抗胰蛋白酶的方法
WO2012125487A1 (en) * 2011-03-11 2012-09-20 Omni Bio Pharmaceutical, Inc. Compositions, methods and uses for radioprotectants
WO2012175672A2 (en) * 2011-06-24 2012-12-27 Baden-Württemberg Stiftung Ggmbh Diagnosis and/or prognosis of parkinson's disease dementia
US8986688B2 (en) * 2011-06-28 2015-03-24 Inhibrx, Llc WAP domain fusion polypeptides and methods of use thereof
CN102993298B (zh) * 2012-12-14 2014-04-09 成都蓉生药业有限责任公司 一种制备α1-抗胰蛋白酶的方法

Also Published As

Publication number Publication date
CN103804484A (zh) 2014-05-21
CA2930049A1 (en) 2015-07-30
AU2014379070A1 (en) 2016-05-12
CN103804484B (zh) 2016-03-16
AU2018203565A1 (en) 2018-06-07
NZ719356A (en) 2017-12-22
WO2015109604A1 (zh) 2015-07-30
RU2703176C2 (ru) 2019-10-15
KR20160111909A (ko) 2016-09-27
AU2018203565B2 (en) 2019-11-14
EP3098233A4 (en) 2017-06-21
RU2016133855A (ru) 2018-03-01
US20160326226A1 (en) 2016-11-10
JP6434525B2 (ja) 2018-12-05
JP2017506221A (ja) 2017-03-02
EP3098233A1 (en) 2016-11-30
RU2016133855A3 (zh) 2018-03-01

Similar Documents

Publication Publication Date Title
HK1251551A1 (zh) 氮雜環丁烷衍生物、其製備方法及用途
ZA201805065B (en) Hair growth composition and method
GB2539729B (en) Transparent frozen soil, and preparation method and application thereof
EP3299369A4 (en) Pyrido-azaheterecydic compound and preparation method and use thereof
SG11201608711RA (en) Material itq-55, method for preparation and use
EP3115361A4 (en) Heterocyclic compounds, and preparation method and use thereof
EP3246327A4 (en) 3-acetylenyl-pyrazole-pyrimidine derivative, and preparation method therefor and uses thereof
EP3372596A4 (en) METHOD FOR THE PRODUCTION OF TEDIZOLIDE, TEDIZOLIDE INTERMEDIATE PRODUCTION AND METHOD OF MANUFACTURING THEREOF
EP3210634A4 (en) Microcarrier adjustment method, microcarrier, and application thereof
EP3285598A4 (en) Food preparation and method
SG11202007554TA (en) Dioxazoline compound, preparation method therefor, and uses thereof
EP3395366C0 (en) METHOD FOR DESIGNING A DRUG, DRUG OBTAINED AND ASSOCIATED APPLICATION
EP3093296A4 (en) Fuc3s4s substituted oligoglycosaminoglycan and preparation method thereof
EP3112351A4 (en) Naphthylamide compound, preparation method and use thereof
HK1243437A1 (zh) 一類三肽化合物及其製備方法與應用
EP3157016A4 (en) Scintillator, preparing method thereof, and application thereof
HK1243995A1 (zh) α-細辛醇酯及其製備方法與應用
EP3243823A4 (en) Mangiferin-6-o-berberine salt and preparation method and use thereof
EP3146968A4 (en) K2 composition, preparation method therefor, and application thereof
SG10201603101YA (en) Lubricant composition, and preparation method and use thereof
EP3231455A4 (en) Biocompatible composition and method for preparing same
EP3132790A4 (en) Exenatide-containing composition and preparation method therefor
IL254597A0 (en) Crystalline form of ahu377, method for its preparation and use
EP3239168A4 (en) Conotoxin peptide -cptx-btl02, preparation method therefor, and uses thereof
HK1226085A1 (zh) 一種網紅細胞生長因子及其製備方法和應用